Molecular Detection

Molecular Detection develops a portfolio of sample-to-answer molecular diagnostic tests for detecting infectious diseases.

Molecular Detection Inc. (MDI) is developing and commercializing a portfolio of 'sample-to-answer' Detect-Readyâ„¢ molecular diagnostic tests for the rapid detection of infectious diseases. The company is preparing to launch its first product, the Detect-Ready assay for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA), a growing problem among hospitals and other health facilities around the globe.